Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
Medication Adherence Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... marketers and senior management with the critical information they need to assess the global medication adherence market. Reasons to Purchase Outperform competitors using accurate up to date demand-side dynamics information. Understand how the market is ... Read More
-
Ulcerative Colitis - Epidemiology Forecast to 2029
... innermost layer of the lining of the intestine. In UC, ulcers develop on the surface of the bowel lining; these may bleed and produce mucus. If the inflammation is confined to rectum, it is called ... Read More
-
Digestive Remedies in the US
... Although the official recall was in April, many bricks-and-mortar retailers such as CVS and Walgreens had already taken Zantac and other generic ranitidine products off their shelves in late 2019. With COVID-19 fears leading to ... Read More
-
Digestive Remedies in New Zealand
... for digestive remedies during the initial lockdown, when consumers stockpiled goods through fear they would not be able to access supplies in the coming months. Euromonitor International's Digestive Remedies in New Zealand report offers a ... Read More
-
Digestive Remedies in Brazil
... as the closure of restaurants, bars and shopping malls were implemented to keep people at home as much as possible. As a consequence, many consumers started cooking more of their own meals at home, a ... Read More
-
Digestive Remedies in Australia
... factors – COVID-19 and the withdrawal of products containing ranitidine. Greater demand for digestive remedies was seen at the beginning of the COVID-19 pandemic in Australia, when panic-buying of many products was seen, including digestive ... Read More
-
Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025
... projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. Market growth is driven by the rising prevalence of cancer, the rapid ... Read More
-
Global Gastrointestinal Partnering 2014-2020: Deal trends, players and financials
... in Gastrointestinal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gastrointestinal partnering agreement structure Gastrointestinal partnering contract documents Top Gastrointestinal deals by value Most active Gastrointestinal dealmakers Most of ... Read More
-
Gastric Ulcers - Pipeline Review, H2 2020
... landscape. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, retching, nausea or vomiting and ... Read More
-
Gastrointestinal Drugs Investment Global Outlook 2020
... disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak.. The market is then expected to recover and grow at a CAGR of -1.35% from ... Read More
-
Gastrointestinal Stents Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026
... shape up the future of the Gastrointestinal Stents market including the COVID-19 pandemic implications for Gastrointestinal Stentss industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives ... Read More
-
Gastric and Gastroesophageal Junction Adenocarcinoma - Epidemiology Forecast to 2029
... gastric cancer cases are considered to be an adenocarcinoma, a cancer that develops in the mucosa—the innermost layer of the stomach. Gastric cancer usually develops slowly and rarely shows any signs or symptoms in the ... Read More
-
2024 Global H. Pylori Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed.. The report provides the 5-year test volume and sales ... Read More
-
Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030
... Italy, France, and United Kingdom) and Japan. The Gastroparesis market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Gastroparesis market size from 2017 to 2030.The ... Read More
-
Gastroparesis - Epidemiology Forecast - 2030
... Japan. Gastroparesis Understanding Gastroparesis, which is a translated meaning of “stomach paralysis”, is a digestive disorder characterized by delayed gastric emptying of solid food in the absence of mechanical obstruction of the stomach, resulting in ... Read More
-
Gastrointestinal Stents
... a revised size of US$457.1 Million by 2027, growing at a CAGR of 2.9% over the analysis period 2020-2027. Esophageal Stents, one of the segments analyzed in the report, is projected to record a 4.2% ... Read More
-
Digestive Enzyme Supplements
... 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027.Animal, one of the segments analyzed in the report, is projected to ... Read More
-
Diabetic Gastroparesis - Pipeline Review, H2 2020
... landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts of the body, including the vagus nerve, which controls ... Read More
-
Visceral Pain Treatment Market, by Drug Type (Pain modifiers (Tricyclic Anticonvulsant and Tricyclic Antidepressants), Analgesics (Narcotics and NSAID), and Others), by Indication (Chronic prostatitis, Interstitial cystitis, Crohn’s Disease, and Irritable
... Channel (Hospital Pharmacy, Retail Pharmacy and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 Visceral pain is ... Read More
-
Clostridioides difficile Infections Global Clinical Trials Review, H2, 2020
... Clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridioides difficile Infections (Clostridium difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top ... Read More
-
Peptide Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)
... the growth of the market is the growing incidence of metabolic disorders and cancers. According to the National Institute of Health (NIH), in 2018, an estimated 1,735,350 new cases of cancer will be detected in ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2020
... Esophagitis (Gastrointestinal) pipeline landscape. When the liquid content of the stomach refluxes into the oesophagus, that condition is called Gastroesophageal reflux disease (GERD). It is a chronic condition. The symptoms of GERD are nausea, heartburn ... Read More
-
Global Clostridium Difficile Treatment Market 2020-2024
... the forecast period. Our reports on clostridium difficile treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
An Ulcerative Colitis Market Research Report by Drug Type (Anti-TNF Biologics
... to 2025 - Cumulative Impact of COVID-19 The United States Ulcerative Colitis Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue ... Read More
-
Human Microbiome Market Research Report by Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, and Metagenomic Sequencing), by Therapeutic Area (Gastrointestinal Disorders, Metabolic Disorders, Skin D
... by Disease, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19 The United States Human Microbiome Market is projected to grow with a significant CAGR in the forecast period. Economic development ... Read More
